0001225208-20-012462.txt : 20201014
0001225208-20-012462.hdr.sgml : 20201014
20201014110139
ACCESSION NUMBER: 0001225208-20-012462
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201012
FILED AS OF DATE: 20201014
DATE AS OF CHANGE: 20201014
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Young Ray G
CENTRAL INDEX KEY: 0001416453
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00044
FILM NUMBER: 201238477
MAIL ADDRESS:
STREET 1: 77 WEST WACKER DR.
STREET 2: SUITE 4600
CITY: CHICAGO
STATE: IL
ZIP: 60601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Archer-Daniels-Midland Co
CENTRAL INDEX KEY: 0000007084
STANDARD INDUSTRIAL CLASSIFICATION: FATS & OILS [2070]
IRS NUMBER: 410129150
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 77 W. WACKER DR.
CITY: CHICAGO
STATE: IL
ZIP: 60601
BUSINESS PHONE: 312-634-8233
MAIL ADDRESS:
STREET 1: 77 W. WACKER DR.
CITY: CHICAGO
STATE: IL
ZIP: 60601
FORMER COMPANY:
FORMER CONFORMED NAME: ARCHER DANIELS MIDLAND CO
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
X0306
4
2020-10-12
0000007084
Archer-Daniels-Midland Co
ADM
0001416453
Young Ray G
77 WEST WACKER DRIVE
SUITE 4600
CHICAGO
IL
60601
1
Chief Financial Officer
Common Stock
2020-10-12
4
M
0
49020.0000
26.1700
A
448997.6288
D
Common Stock
2020-10-12
4
S
0
49020.0000
50.0160
D
399977.6288
D
Employee stock option (right to buy)
26.1700
2020-10-12
4
M
0
49020.0000
0.0000
D
2021-08-11
Common Stock
49020.0000
31357.0000
D
Sale of shares pursuant to Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.02, inclusive. The reporting person undertakes to provide to ADM, any security holder of ADM, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
Includes 4,369.628807 shares acquired pursuant to the Company's dividend reinvestment plan.
Fully exercisable.
Thuy Vo, Attorney-In-Fact
2020-10-13